Positive expiratory pressure device acceptance by hospitalized children with sickle cell disease is comparable to incentive spirometry

Respiratory Care

Volumn 50, Issue 5, 2005, Pages 624-627

  Hsu, Lewis L ^a,b   Batts, Brenda K ^a   Rau, Joseph L ^c  

^a Hughes Spalding Children's Hospital   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NONE

Author keywords

Acute chest syndrome; Child; Hospital pain management; Incentive spirometry; Intermittent positive expiratory pressure; Patient satisfaction; Respiratory therapy; Sickle cell

Indexed keywords

ACUTE CHEST SYNDROME; ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; EXPIRATORY FLOW; FEMALE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MALE; PATIENT SATISFACTION; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY CARE; SCHOOL CHILD; SICKLE CELL ANEMIA; SPIROMETRY; THORAX PAIN; THORAX WALL; CHILD; COMPARATIVE STUDY; INSTRUMENTATION; LENGTH OF STAY; LUNG DISEASE; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; UNITED STATES;

ANEMIA, SICKLE CELL; CHILD; FEMALE; GEORGIA; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LUNG DISEASES; MALE; PATIENT SATISFACTION; POSITIVE-PRESSURE RESPIRATION; SPIROMETRY;

EID: 22144446831     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342(25):1855-1865.
2. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood, 1994;84(2):643-649.
3. Knight J, Murphy TM, Browning I. The lung in sickle cell disease. Pediatric Pulmonology 1999;28(3):205-216.
4. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995;333(11):699-703.
5. Co JP, Johnson KB, Duggan AK, Casella JF, Wilson M. Does a clinical pathway improve the quality of care for sickle cell anemia? Joint Commission Journal on Quality & Safety 2003;29(4):181-90.
6. Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003;120(5):744-752.
7. Lane PA, Buchanan GR, Hutter JJ, Austin RF, Britton HA, Rogers ZR, et al, for the Sickle Cell Disease Care Consortium (Arizona, Colorado, Georgia, Missouri, New Mexico, Tennessee, Texas, and Utah). Sickle cell disease in children and adolescents: diagnosis, guidelines for comprehensive care, and care paths and protocols for management of acute and chronic complications. Available at http:// www.scinfo.org/protpainip.htm. Accessed March 8, 2005.
8. Sanchez Riera H, Dapena Fernandez FJ, Gomez Dominguez F, Ortega Ruiz F, Elias Hernandez T, Montemayor Rubio T, Castillo Gomez J. [Comparative study of the efficacy of 2 respiratory physiotherapy protocols for patients with cystic fibrosis]. Arch Bronconeumol 1999;35(6):275-279.
9. Stock MC, Downs JB, Gauer PK, Alster JM, Imrey PB. Prevention of postoperative pulmonary complications with CPAP, incentive spirometry, and conservative therapy. Chest 1985;87(2):151-157.